Levi &Korsinsky, LLP notifies investors in Celsius Holdings, Inc. (“Celsius” or the “Company”) (NASDAQ: CELH) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Celsius investors who were adversely affected by alleged securities fraud between February 29, 2024 and September 4, 2024. Follow the link below […]

Levi & Korsinsky, LLP notifies investors inPacira BioSciences, Inc. (“Pacira” or the “Company”) (NASDAQ: PCRX) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Pacira investors who were adversely affected by alleged securities fraud between August 2, 2023 and August 8, 2024. Follow the link below

Levi & Korsinsky, LLP notifies investors in BioAge Labs, Inc. (“BioAge” or the “Company”) (NASDAQ: BIOA) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of BioAge investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of all shareholders that purchased stock

Levi & Korsinsky, LLP notifies investors in Micron Technology, Inc. (“Micron” or the “Company”) (NASDAQ: MU) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Micron investors who were adversely affected by alleged securities fraud between September 28, 2023 and December 18, 2024. Follow the link

Levi & Korsinsky, LLP notifies investors in Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQ: REGN) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Regeneron investors who were adversely affected by alleged securities fraud between November 2, 2023 and October 30, 2024. Follow the link

NEW YORK , Jan. 21, 2025 Levi & Korsinsky, LLP notifies investors in Revance Therapeutics, Inc. (“Revance” or the “Company”) (NASDAQ: RVNC) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Revance investors who were adversely affected by alleged securities fraud between February 29, 2024 and

Levi &Korsinsky, LLP notifies investors in Nextracker Inc. (“Nextracker” or the “Company”) (NASDAQ: NXT) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Nextracker investors who were adversely affected by alleged securities fraud between February 1, 2024 and August 1, 2024. Follow the link below to

Levi &Korsinsky, LLP notifies investors in Caribou Biosciences, Inc. (“Caribou Biosciences, Inc.” or the “Company”) (NASDAQ: CRBU) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Caribou Biosciences, Inc. investors who were adversely affected by alleged securities fraud between July 14, 2023 and July 16, 2024.

Levi & Korsinsky, LLP notifies investors in Transocean Ltd. (“Transocean Ltd.” or the “Company”) (NYSE: RIG) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Transocean Ltd. investors who were adversely affected by alleged securities fraud between October 31, 2023 and September 2, 2024. Follow the

Levi &Korsinsky, LLP notifies investors in AstraZeneca PLC (“AstraZeneca” or the “Company”) (NASDAQ: AZN) of a class action securities lawsuit. https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of AstraZeneca investors who were adversely affected by alleged securities fraud between February 23, 2022 and December 17, 2024. Follow the link below to